NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
Estimated value
£424.0m
Awarded value
£1
Suppliers
1
Lots
1
Published
14 May 2024
Description
Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)
Scope
- Reference
- CF-2353600D0O000000rwimUAA
- Total value
- £424,035,364 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 May 2024 to 30 May 2027
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 23 Nov 2023, 1:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£1
Award date
04 Mar 2024
Contract start
31 May 2024
Contract end
30 May 2027